Sepsis & infection

Evaluation of the need for dosing adaptations in obese patients for surgical antibiotic prophylaxis: a model-based analysis of cefazolin pharmacokinetics

Br J AnaesthPublished Pharmacokinetic modelling study

Authors' conclusion

This model-based analysis, using fT>MIC = 100% as a target, showed that cefazolin dosing adaptations are not required for surgical prophylaxis in obese patients.

Study context

Population
Obese and nonobese patients receiving 2 g cefazolin i.v. for surgical infection prophylaxisage- and sex-matched
Participants
15 vs 15
Comparison
Obese vs Nonobese
  • Obesen = 15
  • Nonobesen = 15reference
Outcome
PTA and CFR in plasma and adipose tissue interstitial space fluid (ISF) for target fT>MIC = 100% (regimen adequate when PTA and CFR ≥90%)
Methodological detailsmodel-based analysis, nonlinear mixed-effects modelling, tissue microdialysis, age- and sex-matched
  • Model-based analysis
  • Nonlinear mixed-effects modelling
  • Tissue microdialysis
  • Age- and sex-matched

Main finding

As reported in the abstract

Most suitable cefazolin dosing regimen
GroupProbability of target attainment (PTA)Cumulative fraction of response (CFR)
Obese>90%>90%
Nonobese>90%>90%

Probability of target attainment (PTA)

Obese>90%
Nonobese>90%

Cumulative fraction of response (CFR)

Obese>90%
Nonobese>90%

Original publication

Evaluation of the need for dosing adaptations in obese patients for surgical antibiotic prophylaxis: a model-based analysis of cefazolin pharmacokinetics. Br J Anaesth. Published 1 February 2025. doi:10.1016/j.bja.2024.11.044

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.